Dare Bioscience Inc (NASDAQ:DARE)
| 0.3519 Delayed Data As of Dec 01 |  +0.0019 / +0.54%Today’s Change | 0.28 Today|||52-Week Range 1.40 | -57.60% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $35.1M |
Company Description
Daré Bioscience, Inc. operates as a healthcare company, which engages in the development and commercialization of pharmaceutical products in women's reproductive health. Its products include Ovaprene and Topical Sildenafil. The company was founded by Sabrina Martucci Johnson, Lisa Walters-Hoffert and Roger L. Hawley in 2015 and is headquartered in San Diego, CA.
Contact Information
Daré Bioscience, Inc. 3655 Nobel Drive San Diego California 92122 |
Employees
Shareholders
| Other institutional | 9.54% |
| Mutual fund holders | 5.03% |
| Individual stakeholders | 3.11% |
Top Executives
| Sabrina Martucci Johnson | President, CEO, Secretary & Director |
| Mark Walters | Vice President-Operations |
| Lisa Walters-Hoffert | Chief Financial Officer |
| Christine Mauck | Medical Director |
| David Friend | Chief Scientific Officer |
